查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
鼻咽拭子市場 - 成長、未來前景、競爭分析，2023-2031
市場調查報告書
商品編碼
1347826

鼻咽拭子市場 - 成長、未來前景、競爭分析，2023-2031

Nasopharyngeal Swabs Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

預計 2023 年至 2031 年期間，鼻咽拭子市場將以 2.5% 的複合年增長率成長，特別是在 COVID-19 大流行期間診斷測試需求增加的推動下。鼻咽拭子廣泛用於採集呼吸道標本，並可檢測流感、呼吸道合胞病毒 (RSV) 和引起 COVID-19 的病毒 SARS-CoV-2 等傳染病。促進市場成長的主要因素之一是醫療保健專業人員和公眾對早期發現疾病的重要性的認識不斷提高。鼻咽拭子是診斷測試的首選，因為它們提供了一種非侵入性且可靠的呼吸道檢體採集方法。此外，即時檢測設施的激增進一步推動了對鼻咽拭子的需求。市場收入大幅成長，主要是由於大流行期間對 COVID-19 檢測的空前需求。隨著世界各國政府和醫療機構大力投資診斷檢測基礎設施，鼻咽拭子的使用量激增。此外，持續的研發活動引入了創新的拭子設計，可提高患者舒適度和樣本採集效率，進一步推動市場成長。然而，市場並非沒有挑戰。醫療器材嚴格的監管要求和不同的地區報銷政策可能會抑制鼻咽拭子的成長。此外，替代樣本採集方法（例如基於唾液的測試）的出現可能對市場擴張構成潛在威脅。

COVID-19 大流行期間診斷測試的需求增加

COVID-19大流行是鼻咽拭子市場的主要驅動因素。由於需要進行廣泛的診斷測試來識別病毒並控制其傳播，對鼻咽拭子的需求激增。世界各地的政府和醫療機構在測試基礎設施上投入巨資，促進了市場的成長。在大流行期間，許多國家報告稱，由於前所未有的需求，鼻咽拭子已經用完。例如，2020年初，美國面臨供應短缺，政府採取措施增加拭子的生產和向檢測設施的分配。其他地區的類似報告突顯了大流行期間對鼻咽拭子的需求激增。

拭子設計的進步可提高病患舒適度和檢體採集效率

醫療保健產業的持續研究和開發工作顯著改善了鼻咽拭子的設計。這些創新的重點是提高樣本採集過程中患者的舒適度，減少手術的侵入性，並提高樣本採集效率。醫學期刊上發表的研究報告了拭子設計的各種進展。其中包括開發靈活、更柔軟、尺寸更小的棉籤，在樣本採集過程中不會引起患者不適。研究論文還強調了新拭子設計在收集足夠樣本以進行準確診斷測試方面的有效性，並強調了持續改進拭子技術的重要性。

提高對早期疾病檢測和即時檢測設施的認識

醫療保健專業人員和公眾對早期疾病檢測重要性的認識不斷提高，推動了鼻咽拭子的採用。即時檢測設施現已廣泛使用，使個人更容易快速接受檢測並快速獲得結果。公共衛生運動、媒體通報和教育活動強調及早發現疾病的重要性。因此，人們變得更願意接受診斷測試，其中通常包括鼻咽拭子。此外，在診所、藥房和社區中心建立即時檢測設施使檢測變得更加容易和方便，進一步增加了對鼻咽拭子的需求。

醫療器材嚴格監管要求

由於對包括拭子在內的醫療器材實施嚴格的監管要求，鼻咽拭子市場面臨重大限制因素。各個地區的監管機構都要求在允許拭子進入市場之前進行嚴格的測試、安全評估和品質控制措施。這些要求通常會導致製造商的審批時間更長並增加成本。例如，美國食品藥物管理局 (FDA) 要求拭子製造商在銷售其產品之前遵守上市前通知流程 (510(k)) 或獲得上市前批准 (PMA)。同樣，歐盟 (EU) 的 CE 標記流程要求進行合格評定並遵守醫療器械的基本健康和安全要求。這些嚴格的監管障礙可能會推遲產品上市並阻止中小型製造商進入鼻咽拭子市場，從而影響整體市場成長。因此，公司必須投入大量時間和資源來確保遵守監管準則，這可能會阻礙創新並限制市場擴張。著名醫學期刊上發表的研究論文和文章討論了醫療器材製造商在滿足鼻咽拭子監管要求方面面臨的挑戰。這些報告詳細介紹了獲得監管部門批准所需的複雜流程和大量文件。此外，該案例研究還描述了公司如何因嚴格的監管要求而在將鼻咽拭子推向市場時面臨延誤和障礙。

泡棉棉籤在預測期內帶來商機

在市場上提供的各種類型的鼻咽拭子中，泡沫尖端拭子預計在 2023 年至 2031 年的預測期內將表現出最高的複合年增長率。泡沫拭子因其在樣本採集和患者舒適度方面的卓越性能而越來越受歡迎。柔軟、有彈性的泡棉材質可最大限度地減少採樣過程中鼻腔不適或受傷的風險，使其受到醫療保健專業人員和患者的青睞。此外，事實證明，泡沫頭拭子可以非常有效地收集足夠的樣本以進行準確的診斷測試，這使得它們在包括COVID-19 在內的各種呼吸道感染中得到越來越多的採用。我是。因此，在 COVID-19 大流行期間，對尖頭拭子的需求大幅增加，從而促進了收入的大幅增長。另一方面，非織造拭子的複合年增長率和收入相對較低。儘管無紡棉籤被廣泛使用且容易獲得，但它們通常被認為不如泡棉頭棉籤舒適且效率較低。與不織布拭子相比，人們更喜歡泡沫頭拭子，這可以從其在鼻咽拭子市場中更高的採用率和收入證明。最後， "其他" 類別包括除泡沫頭和不織布之外的各種類型的鼻咽拭子，但它們佔市場份額很小。雖然這個細分市場提供了一個利基選擇，但它面臨著與泡沫頭拭子的卓越性能和可接受性競爭的挑戰。總體而言，泡沫頭棉籤已成為鼻咽拭子市場中明顯的領跑者，由於其卓越的效率、患者舒適度以及COVID-19 大流行期間需求的增加，其複合年增長率最高，體驗並產生最高的回報。

醫院仍然是主要最終用戶

在鼻咽拭子市場的各個最終用戶細分市場中，醫院預計在 2023-2031 年預測期內呈現最高的複合年增長率，並在 2022 年實現收入。醫院是鼻咽拭子的主要消費者，因為它們在呼吸道感染的診斷和治療中發揮重要作用。隨著COVID-19等傳染病的迅速增加，醫院對鼻咽拭子的需求激增，大大貢獻了高額利潤。此外，醫院建立了醫療基礎設施和實驗室，可以進行高效、大規模的檢測，進一步推動了對鼻咽拭子的需求。儘管診所也是重要的消費者，但其複合年增長率和收入相對較低。儘管診所定期進行診斷測試，但測試量可能低於醫院。此外，一些診所選擇替代樣本採集方法，例如基於唾液的測試，影響了該領域鼻咽拭子的成長。學術和研究機構也是重要的最終用戶群體，透過參與科學和臨床研究為鼻咽拭子市場做出貢獻。儘管研究機構產生的收入可能不如醫院和診所那麼多，但由於各種研究和試驗對鼻咽拭子的穩定需求，它們擁有穩定的市場份額。最後， "其他" 類別，包括療養院、家庭醫療保健、工業設施等，與醫院、診所和研究機構相比，其市場份額較小。儘管市場規模較小，但該細分市場仍對整體市場收入做出貢獻，反映了鼻咽拭子在不同環境下的多功能性和廣泛適用性。總之，在鼻咽拭子市場中，醫院的複合年增長率和銷售額最高，成為主導的最終用戶群。這是由於其在疾病診斷中的重要作用以及市場區隔流行期間需求的增加。

亞太地區仍居世界領先地位

北美成為 2023-2031 年預測期內複合年增長率最高的地區。該地區強大的醫療基礎設施、先進診斷技術的廣泛採用以及積極的政府舉措正在推動對鼻咽拭子的需求。COVID-19 的爆發進一步增加了診斷測試的需求，大大促進了該地區的高複合年增長率。此外，北美是幾個積極參與拭子生產和分銷的主要市場參與者的所在地，進一步推動了市場的成長。另一方面，亞太地區是2022年鼻咽拭子市場銷售佔比最高的地區。由於該地區人口眾多，尤其是中國和印度等國家，對診斷檢測的需求很大，推動了鼻咽拭子的採用。此外，人們越來越認識到早期發現疾病的重要性，以及呼吸道感染盛行率的不斷上升，正在推動亞太地區的市場成長。另一個優點是該地區本地生產廠商眾多，保證了鼻咽拭子的穩定供應。由於醫療成本上升、疾病負擔增加以及先進診斷技術的採用，歐洲以及拉丁美洲和中東等其他地區也推動了鼻咽拭子市場的顯著成長。

預測期內市場競爭將加劇

鼻咽拭子市場的主要參與者包括Thermo Fisher Scientific, Inc.、Becton, Dickinson and Company（原CR Bard, Inc.）、Medical Wire & Equipment (MWE)、Titan Biotech Ltd.、COPAN Diagnostics, Inc.，其中包括Miraclean Technology Co. Ltd、Puritan Medical Products、YOCON Biology、Trinity Biotech、VIRCELL SL 和 Quidel Corporation。這些公司以其強大的影響力和對市場的貢獻而聞名。為了保持競爭力，這些公司正在實施各種關鍵舉措，包括拭子設計和材料的持續創新、更有效率的全球市場擴張和分銷、策略聯盟和收購以及遵守嚴格的監管要求等策略。積極的營銷和教育舉措也幫助這些公司提高品牌知名度並擴大其整體市場範圍。除了以產品為中心的策略外，領先的公司還積極採取積極的營銷和教育措施。強調診斷測試的重要性以及鼻咽拭子在疾病早期檢測中的作用的宣傳活動將提高品牌知名度並有助於整體市場擴張。為了保持競爭優勢，這些公司優先考慮遵守嚴格的監管要求。投資獲得監管機構的必要認證和批准可確保產品安全和品質。這不僅體現了對病人安全的承諾，而且還建立了與醫療保健專業人員和最終用戶的信任。

目錄

第一章 前言

  • 報告內容
    • 報告目的
    • 目標聽眾
    • 主要提供產品
  • 市場細分
  • 調查方法
    • 第一階段—二次調查
    • 第二階段-初步調查
    • 第三階段-專家評審
    • 先決條件
    • 採取的方法

第二章執行摘要

第三章 鼻咽拭子市場：競爭分析

  • 主要供應商的市場地位
  • 供應商採取的策略
  • 主要產業戰略
  • 等級分析：2022 年與 2031 年

第四章鼻咽拭子市場：宏觀分析及市場動態

  • 介紹
  • 2021-2031年全球鼻咽拭子市場價值
  • 市場動態
    • 市場驅動力
    • 市場製約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第五章鼻咽拭子市場：依類型2021-2031

  • 市場概況
  • 成長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 附泡沫頭的棉花棒
    • 不織棉籤
    • 其他

第六章 鼻咽拭子市場：依應用分類 2021-2031

  • 市場概況
  • 成長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 流感
    • COVID-19
    • 呼吸道合胞病毒
    • 百日咳博德氏菌感染
    • MRSA（抗甲氧西林金黃色葡萄球菌）
    • 其他

第 7 章 鼻咽拭子市場：依最終使用者分類 2021-2031

  • 市場概況
  • 成長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 醫院
    • 診所
    • 學術研究機構
    • 其他

第八章北美鼻咽拭子市場2021-2031

  • 市場概況
  • 鼻咽拭子市場：依類型 2021-2031
  • 鼻咽拭子市場：依應用劃分 2021-2031
  • 鼻咽拭子市場：依最終使用者分類 2021-2031
  • 鼻咽拭子市場：按地區 2021-2031
    • 北美
      • 美國
      • 加拿大
      • 其他北美

第9章英國及歐盟鼻咽拭子市場2021-2031

  • 市場概況
  • 鼻咽拭子市場：依類型 2021-2031
  • 鼻咽拭子市場：依應用劃分 2021-2031
  • 鼻咽拭子市場：依最終使用者分類 2021-2031
  • 鼻咽拭子市場：按地區 2021-2031
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 意大利
      • 法國
      • 歐洲其他地區

第10章亞太鼻咽拭子市場2021-2031

  • 市場概況
  • 鼻咽拭子市場：依類型 2021-2031
  • 鼻咽拭子市場：依應用劃分 2021-2031
  • 鼻咽拭子市場：依最終使用者分類 2021-2031
  • 鼻咽拭子市場：按地區 2021-2031
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 亞太其他地區

第十一章拉丁美洲鼻咽拭子市場2021-2031

  • 市場概況
  • 鼻咽拭子市場：依類型 2021-2031
  • 鼻咽拭子市場：依應用劃分 2021-2031
  • 鼻咽拭子市場：依最終使用者分類 2021-2031
  • 鼻咽拭子市場：按地區 2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第十二章中東和非洲鼻咽拭子市場2021-2031

  • 市場概況
  • 鼻咽拭子市場：依類型 2021-2031
  • 鼻咽拭子市場：依應用劃分 2021-2031
  • 鼻咽拭子市場：依最終使用者分類 2021-2031
  • 鼻咽拭子市場：按地區 2021-2031
    • 中東/非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東/非洲地區

第十三章公司簡介

  • Thermo Fisher Scientific Inc.
  • Becton Dickinson and Company（formerly C. R. Bard Inc.）
  • Medical Wire & Equipment（MWE）
  • Titan Biotech Ltd.
  • COPAN Diagnostics Inc.
  • Miraclean Technology Co. Ltd.
  • Puritan Medical Products
  • YOCON Biology
  • Trinity Biotech
  • VIRCELL S.L
  • Quidel Corporation
  • 其他主要公司
Product Code: 139749-08-23

The nasopharyngeal swabs market is expected to grow at a CAGR of 2.5% during the forecast period of 2023 to 2031, driven by the increasing demand for diagnostic testing, particularly during the COVID-19 pandemic. nasopharyngeal swabs are widely used for the collection of respiratory specimens, enabling the detection of infectious diseases, including influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, the virus responsible for COVID-19. One of the key factors contributing to the market's growth is the rising awareness among healthcare professionals and the general public about the importance of early disease detection. nasopharyngeal swabs offer a non-invasive and reliable method to collect respiratory specimens, making them a preferred choice for diagnostic testing. Additionally, the widespread availability of point-of-care testing facilities has further boosted the demand for nasopharyngeal swabs. The market's revenue has witnessed a substantial surge, primarily due to the unprecedented demand for COVID-19 testing during the pandemic. Governments and healthcare organizations across the globe invested heavily in diagnostic testing infrastructure, leading to a surge in the adoption of nasopharyngeal swabs. Moreover, ongoing research and development activities have led to the introduction of innovative swab designs that enhance patient comfort and sample collection efficiency, further driving market growth. However, the market is not without its challenges. Stringent regulatory requirements for medical devices and variations in reimbursement policies across different regions can hinder the growth of nasopharyngeal swabs. Additionally, the emergence of alternative specimen collection methods, such as saliva-based testing, may pose a potential threat to the market's expansion.

Increased Demand for Diagnostic Testing During the COVID-19 Pandemic

The COVID-19 pandemic has been a significant driver of the nasopharyngeal swabs market. The need for widespread diagnostic testing to identify and control the spread of the virus led to a surge in demand for nasopharyngeal swabs. Governments and healthcare organizations worldwide invested heavily in testing infrastructure, contributing to the market's growth. During the pandemic, there were numerous reports of countries experiencing shortages of nasopharyngeal swabs due to unprecedented demand. For instance, in early 2020, the United States faced supply constraints, prompting the government to take measures to increase the production and distribution of swabs to testing facilities. Similar reports emerged from other regions, highlighting the surging demand for nasopharyngeal swabs during the pandemic.

Advancements in Swab Design for Enhanced Patient Comfort and Sample Collection Efficiency

The continuous research and development efforts in the healthcare industry have led to significant improvements in nasopharyngeal swab design. These innovations have focused on increasing patient comfort during sample collection, reducing the invasiveness of the procedure, and improving sample collection efficiency. Published studies in medical journals have reported on various advancements in swab design. These include the development of flexible, softer, and smaller-sized swabs that cause less discomfort to patients during sample collection. Research papers have also highlighted the efficacy of novel swab designs in collecting adequate samples for accurate diagnostic testing, reinforcing the importance of ongoing improvements in swab technology.

Growing Awareness of Early Disease Detection and Point-of-Care Testing Facilities

The increasing awareness among healthcare professionals and the general public about the importance of early disease detection has driven the adoption of nasopharyngeal swabs. Point-of-care testing facilities have become more widely available, making it easier for individuals to get tested quickly and receive prompt results. Public health campaigns, media coverage, and educational initiatives have emphasized the significance of early disease detection. As a result, people are more inclined to undergo diagnostic testing, which often involves nasopharyngeal swabs. Moreover, the establishment of point-of-care testing facilities in clinics, pharmacies, and community centers has made testing more accessible and convenient, further contributing to the demand for nasopharyngeal swabs.

Stringent Regulatory Requirements for Medical Devices

The nasopharyngeal swabs market faces a significant restraint due to the stringent regulatory requirements imposed on medical devices, including swabs. Regulatory authorities across different regions mandate rigorous testing, safety evaluations, and quality control measures before allowing swabs to enter the market. These requirements often lead to longer approval timelines and higher costs for manufacturers. For instance, the U.S. Food and Drug Administration (FDA) requires swab manufacturers to comply with the premarket notification process (510(k)) or obtain premarket approval (PMA) before marketing their products. Similarly, the European Union's CE marking process entails conformity assessments and compliance with essential health and safety requirements for medical devices. These stringent regulatory hurdles can delay product launches and inhibit smaller manufacturers from entering the nasopharyngeal swabs market, impacting overall market growth. As a result, companies must invest significant time and resources to ensure compliance with regulatory guidelines, potentially hindering innovation and restricting market expansion. Published research papers and articles in reputable medical journals discuss the challenges faced by medical device manufacturers in meeting regulatory requirements for nasopharyngeal swabs. These reports detail the complex processes and substantial documentation necessary for obtaining approvals from regulatory authorities. Additionally, case studies highlight instances where companies faced delays and hurdles in introducing nasopharyngeal swabs to the market due to stringent regulatory demands.

Foam-Tipped Swabs to Promise Opportunities During the Forecast Period

Among the different types of nasopharyngeal swabs available in the market, foam-tipped swabs are expected to exhibit the highest CAGR during the forecast period of 2023 to 2031. Foam-tipped swabs are gaining popularity due to their superior performance in sample collection and patient comfort. The soft and flexible foam material minimizes the risk of causing discomfort or injury to the nasal passage during sample collection, making them preferable for both healthcare professionals and patients. Moreover, foam-tipped swabs have demonstrated higher efficiency in collecting an adequate sample for accurate diagnostic testing, leading to increased adoption in various respiratory infections, including COVID-19. As a result, foam-tipped swabs have experienced a significant surge in demand during the COVID-19 pandemic, contributing to their remarkable revenue growth. Non-woven swabs, on the other hand, have shown a comparatively lower CAGR and revenue. Although non-woven swabs are widely used and readily available, they are often perceived to be less comfortable and efficient than foam-tipped swabs. The preference for foam-tipped swabs over non-woven swabs is evident from their higher adoption rates and revenue in the nasopharyngeal swabs market. Lastly, the "Others" category, which includes various types of nasopharyngeal swabs apart from foam-tipped and non-woven, accounts for a smaller portion of the market share. While this segment offers some niche options, it faces challenges in competing with the superior performance and acceptance of foam-tipped swabs. Overall, foam-tipped swabs have emerged as the clear frontrunner in the nasopharyngeal swabs market, experiencing the highest CAGR and generating the highest revenue due to their exceptional efficiency, patient comfort, and increased demand during the COVID-19 pandemic.

Hospitals Remain the Key End Users

Among the various end-user segments in the nasopharyngeal swabs market, hospitals are expected to exhibit the highest CAGR during the forecast period of 2023 to 2031 and revenue generated in 2022. Hospitals are the primary consumers of nasopharyngeal swabs due to their critical role in diagnosing and treating a wide range of respiratory infections. With the surge in infectious diseases like COVID-19, hospitals' demand for nasopharyngeal swabs has skyrocketed, contributing significantly to their high revenue generation. Moreover, hospitals have well-established healthcare infrastructure and laboratories, allowing for efficient and large-scale testing, further boosting the demand for nasopharyngeal swabs. Clinics, although also significant consumers have shown a comparatively lower CAGR and revenue. While clinics regularly perform diagnostic testing, they may have less capacity for testing volume compared to hospitals. Additionally, some clinics may opt for alternative specimen collection methods, such as saliva-based testing, impacting the growth of nasopharyngeal swabs in this segment. Academia & research institutes represent another important end-user segment, contributing to the nasopharyngeal swabs market through their involvement in scientific studies and clinical research. While research institutions may not generate as much revenue as hospitals and clinics, their consistent demand for nasopharyngeal swabs for various studies and trials ensures a stable market share. Lastly, the "Others" category, including settings like nursing homes, home healthcare, and industrial facilities, holds a smaller market share compared to hospitals, clinics, and research institutes. Despite its smaller size, this segment still contributes to the overall market revenue, reflecting the versatility and broad applicability of nasopharyngeal swabs across diverse settings. In conclusion, hospitals stand out as the dominant end-user segment in the nasopharyngeal swabs market, with the highest CAGR and revenue, driven by their crucial role in disease diagnosis and the heightened demand during the COVID-19 pandemic.

APAC remains the Global Leader

North America has emerged as the region with the highest CAGR during the forecast period of 2023 to 2031. The robust healthcare infrastructure, extensive adoption of advanced diagnostic technologies, and proactive government initiatives in the region have fueled the demand for nasopharyngeal swabs. The outbreak of COVID-19 further intensified the need for diagnostic testing, contributing significantly to the region's high CAGR. Additionally, North America houses several key market players actively involved in swab production and distribution, further driving market growth. On the other hand, Asia-Pacific held the distinction of being the region with the highest revenue percentage in the nasopharyngeal swabs market in 2022. The region's large population, especially in countries like China and India, has translated into a substantial demand for diagnostic testing, boosting the adoption of nasopharyngeal swabs. Furthermore, growing awareness of the importance of early disease detection and the increasing prevalence of respiratory infections have driven market growth in Asia-Pacific. The region also benefits from the presence of a significant number of local manufacturers, ensuring a steady supply of nasopharyngeal swabs. Europe and other regions, such as Latin America and the Middle East, have also experienced notable growth in the nasopharyngeal swabs market, driven by increasing healthcare expenditures, rising disease burden, and the adoption of advanced diagnostic technologies.

Market Competition to Intensify during the Forecast Period

Among the top players in the nasopharyngeal swabs market are Thermo Fisher Scientific, Inc., Becton, Dickinson and Company (formerly C. R. Bard, Inc.), Medical Wire & Equipment (MWE), Titan Biotech Ltd., COPAN Diagnostics, Inc., Miraclean Technology Co., Ltd., Puritan Medical Products, YOCON Biology, Trinity Biotech, VIRCELL S.L, and Quidel Corporation. These companies are known for their strong presence and contribution to the market. They employ various key strategies to stay competitive, including continuous innovation in swab designs and materials, global market reach and distribution efficiency, strategic partnerships and acquisitions, and compliance with stringent regulatory requirements. Proactive marketing and educational initiatives also help these companies increase their brand visibility and expand the overall market. In addition to product-focused strategies, top players actively engage in proactive marketing and educational initiatives. Awareness campaigns highlighting the importance of diagnostic testing and the role of nasopharyngeal swabs in early disease detection help increase brand visibility and contribute to overall market expansion. To maintain their competitive advantage, these companies prioritize compliance with stringent regulatory requirements. Investments in obtaining necessary certifications and approvals from regulatory authorities ensure the safety and quality of their products. This not only demonstrates their commitment to patient safety but also builds trust among healthcare professionals and end-users.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofNasopharyngeal Swabs market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Nasopharyngeal Swabs market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • Foam Tipped Swabs
  • Non-woven Swabs
  • Others

Application

  • Influenza
  • COVID-19
  • Respiratory Syncytial Virus
  • Bordetella Pertussis Infection
  • MRSA (Methicillin-resistant Staphylococcus aureus)
  • Others

End-user

  • Hospitals
  • Clinics
  • Academia & Research Institutes
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Nasopharyngeal Swabs market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Nasopharyngeal Swabs market?
  • Which is the largest regional market for Nasopharyngeal Swabs market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Nasopharyngeal Swabs market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Nasopharyngeal Swabs market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Nasopharyngeal Swabs Market
  • 2.2. Global Nasopharyngeal Swabs Market, By Type, 2022 (US$ Million)
  • 2.3. Global Nasopharyngeal Swabs Market, By Application, 2022 (US$ Million)
  • 2.4. Global Nasopharyngeal Swabs Market, By End-user, 2022 (US$ Million)
  • 2.5. Global Nasopharyngeal Swabs Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Nasopharyngeal Swabs Market: Competitive Analysis

  • 3.1. Market Positioning of Key Nasopharyngeal Swabs Market Vendors
  • 3.2. Strategies Adopted by Nasopharyngeal Swabs Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Nasopharyngeal Swabs Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Nasopharyngeal Swabs Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Foam Tipped Swabs
    • 5.3.2. Non-woven Swabs
    • 5.3.3. Others

6. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Influenza
    • 6.3.2. COVID-19
    • 6.3.3. Respiratory Syncytial Virus
    • 6.3.4. Bordetella Pertussis Infection
    • 6.3.5. MRSA (Methicillin-resistant Staphylococcus aureus)
    • 6.3.6. Others

7. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Academia & Research Institutes
    • 7.3.4. Others

8. North America Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 8.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 8.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 8.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

9. UK and European Union Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 9.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 9.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 9.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.4.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.5.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.6.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

10. Asia Pacific Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 10.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 10.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 10.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.4.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.5.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.6.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

11. Latin America Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 11.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 11.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 11.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

12. Middle East and Africa Nasopharyngeal Swabs Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
  • 12.3. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
  • 12.4. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
  • 12.5.Nasopharyngeal Swabs Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.1.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.2.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Nasopharyngeal Swabs Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.3.2. Nasopharyngeal Swabs Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.3. Nasopharyngeal Swabs Market: By End-user, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Thermo Fisher Scientific, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Becton, Dickinson and Company (formerly C. R. Bard, Inc.)
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Medical Wire & Equipment (MWE)
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Titan Biotech Ltd.
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. COPAN Diagnostics, Inc.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Miraclean Technology Co., Ltd.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Puritan Medical Products
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. YOCON Biology
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Trinity Biotech
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. VIRCELL S.L
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Quidel Corporation
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. Other Notable Players
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 3 Global Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 4 North America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 5 North America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 6 North America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 7 U.S. Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 8 U.S. Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 9 U.S. Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 10 Canada Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 11 Canada Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 12 Canada Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 19 UK Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 20 UK Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 21 UK Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 22 Germany Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 23 Germany Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 24 Germany Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 25 Spain Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 26 Spain Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 27 Spain Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 28 Italy Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 29 Italy Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 30 Italy Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 31 France Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 32 France Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 33 France Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 37 Asia Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 38 Asia Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 39 Asia Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 40 China Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 41 China Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 42 China Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 43 Japan Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 44 Japan Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Japan Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 46 India Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 47 India Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 48 India Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 49 Australia Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 50 Australia Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 51 Australia Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 52 South Korea Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 53 South Korea Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 54 South Korea Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 55 Latin America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 56 Latin America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 57 Latin America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 58 Brazil Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 59 Brazil Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 60 Brazil Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 61 Mexico Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 62 Mexico Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 63 Mexico Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 70 GCC Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 71 GCC Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 72 GCC Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 73 Africa Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 74 Africa Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 75 Africa Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Nasopharyngeal Swabs Market By Type, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Nasopharyngeal Swabs Market By Application, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Nasopharyngeal Swabs Market By End-user, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Nasopharyngeal Swabs Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Nasopharyngeal Swabs Market: Quality Assurance
  • FIG. 5 Global Nasopharyngeal Swabs Market, By Type, 2022
  • FIG. 6 Global Nasopharyngeal Swabs Market, By Application, 2022
  • FIG. 7 Global Nasopharyngeal Swabs Market, By End-user, 2022
  • FIG. 8 Global Nasopharyngeal Swabs Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Nasopharyngeal Swabs Market, 2022

FIG. 10Market Positioning of Key Nasopharyngeal Swabs Market Players, 2022

FIG. 11Global Nasopharyngeal Swabs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 12 Global Nasopharyngeal Swabs Market, By Type, 2022 Vs 2031, %
  • FIG. 13 Global Nasopharyngeal Swabs Market, By Application, 2022 Vs 2031, %
  • FIG. 14 Global Nasopharyngeal Swabs Market, By End-user, 2022 Vs 2031, %
  • FIG. 15 U.S. Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 22 France Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 24 China Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 26 India Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Nasopharyngeal Swabs Market (US$ Million), 2021 - 2031